Literature DB >> 9282990

Ratio of inner cell mass and trophoblastic cells in blastocysts derived from porcine 4- and 8-cell embryos and isolated blastomeres cultured in vitro in the presence or absence of protein and human leukemia inhibitory factor.

J Eckert1, T Tao, H Niemann.   

Abstract

In this study we investigated effects of developmental stage at onset of individual in vitro culture on the progress of development in intact embryos and individual blastomeres derived from 4-cell and 8-cell porcine embryos (referred to as 1/4 and 1/8, respectively), the necessity of serum or BSA supplementation in culture media for embryos and blastomeres (in contrast to development in a defined medium), and the role of two concentrations of human leukemia inhibitory factor (hLIF) on development of blastomeres and embryos. More (p < 0.05) 1/4 blastomeres developed to the blastocyst stage than did 1/8 blastomeres. In the serum-supplemented medium, the percentage of inner cell mass (ICM)/total cells in 8-cell- and 1/8-derived blastocysts was higher (p < 0.05) than that in 4-cell- and 1/4-derived embryos. Development to blastocysts was similar in BSA-supplemented and defined medium as compared to that in serum-enriched medium in intact 4-cell and 8-cell embryos, and 1/4 blastomeres. More (p < 0.05) 1/8 blastomeres developed to the blastocyst stage in serum-supplemented medium than in defined medium. The high hLIF concentration (1000 IU/ml) decreased (p < 0.05) blastocyst development in 1/4 blastomeres in defined medium, but fewer blastocysts (p > 0.05) lacked an ICM (blastocyst-like vesicles) than in defined medium without hLIF. It is concluded that 1) porcine intact embryos and isolated blastomeres can be cultured individually in defined medium up to the blastocyst stage from the 4-cell stage onwards; 2) more 1/4 isolated blastomeres develop to blastocysts with more total cells but with a lower ratio of ICM to total cells than blastocysts derived from 1/8 blastomeres; 3) the effects of hLIF are dependent on proteins present in the culture medium and on the embryonic stage; and 4) in defined medium, high concentrations of hLIF are inhibitory to blastocyst formation, but fewer blastocyst-like vesicles are formed. The defined culture system employed in this study allows examination of the effects of growth factors or cytokines in porcine early embryonic development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282990     DOI: 10.1095/biolreprod57.3.552

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

1.  Effect of different concentrations of recombinant leukemia inhibitory factor on different development stage of mouse embryo in vitro.

Authors:  H D Tsai; C C Chang; Y Y Hsieh; L W Hsu; S C Chang; H Y Lo
Journal:  J Assist Reprod Genet       Date:  2000-07       Impact factor: 3.412

2.  Developmental potential of isolated blastomeres from early mouse embryos in the presence and absence of LIF and GM-CSF.

Authors:  Behnaz Sheikholslami; Mojdeh Salehnia; Mojtaba Rezazadeh Valojerdi; Mehdi Ramezanzadeh
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

3.  Improved Murine Blastocyst Quality and Development in a Single Culture Medium Compared to Sequential Culture Media.

Authors:  Justin M Hennings; Randall L Zimmer; Henda Nabli; J Wade Davis; Peter Sutovsky; Miriam Sutovsky; Kathy L Sharpe-Timms
Journal:  Reprod Sci       Date:  2015-12-13       Impact factor: 3.060

4.  Modulation of pluripotency in the porcine embryo and iPS cells.

Authors:  Aida Rodríguez; Cinzia Allegrucci; Ramiro Alberio
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

5.  Identification and isolation of embryonic stem cells in reproductive endocrinology: theoretical protocols for conservation of human embryos derived from in vitro fertilization.

Authors:  Eric Scott Sills; Takumi Takeuchi; Noriko Tanaka; Queenie V Neri; Gianpiero D Palermo
Journal:  Theor Biol Med Model       Date:  2005-07-18       Impact factor: 2.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.